Insights On Partnering
-
Clinical Trials In The Age Of Cost Caps
4/14/2025
On February 7, 2025, the NIH introduced a pivotal policy (NOT-OD-25-068), capping indirect cost recovery at 15% for research grants.
-
How To Capture Growth In The Expanding Metabolic Drug Market
12/2/2025
Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.
-
Breaking Free From Process Paralysis In Clinical Trials
1/13/2025
Explore the implementation of CRIO’s eSource solution by a leading pharmaceutical company to overcome process paralysis in clinical research.
-
Benefit From Enhanced Power And Intelligence
8/14/2025
Find a supply automation value engine with intelligent automation and algorithms to analyze drug supply data and automatically adjust delivery quantities to each site based on data available in IRT.
-
Are You An Emerging Biotech? Things To Consider When Selecting A CRO
7/22/2024
Better understand how smaller biotech companies should approach CRO selection and what they should consider before launching their clinical development program.
-
The Ten Commandments Of Vendor Selection
7/1/2025
Selecting the right vendors sets the foundation for efficient operations and reliable outcomes, and these ten essential principles can guide sponsors in making informed vendor choices.
-
The Immune System's Secret Language: Unlocking Cellular Communication
10/15/2025
The rising rate of autoimmune conditions requires better ways to monitor cellular activity. See how profiling immune cells by their DNA signatures enables real-time therapeutic insight and prediction.
-
Targeted Modalities: Trends, Challenges, CDMO Considerations
8/11/2025
Targeted modalities are designed to bind specifically to receptors or biological targets, ensuring a more directed and effective treatment while reducing systemic exposure and unintended side-effects.
-
Reducing Time To First-In-Human Trials With Robotic SFF Services
6/21/2024
Discover how robotic gloveless isolator sterile fill-finish (SFF) systems can accelerate early-phase drug development, ensuring enhanced sterility and streamlined processes for biopharma innovation.
-
Overcoming Issues Of Non-Enrolling Sites In Clinical Trials
1/14/2025
Explore the challenges of non-enrolling sites in clinical trials, focusing on the benefits of leveraging artificial intelligence (AI) and machine learning (ML) in addressing those issues.